[1]
S. Desai, S. Kurli, and H. G., “Comparative study of adverse effect profile of first line drugs Zidovudine (ZDV) + Lamivudine (3TC) + Nevirapine (NVP) Vs Tenofovir (TDF) + Lamivudine (3TC) + Atazanavir (ATV) + Ritonovir (RTV) in HIV/AIDS patients”, Int J Basic Clin Pharmacol, vol. 7, no. 1, pp. 114–120, Dec. 2017.